Coexisting lower urinary tract symptoms and erectile dysfunction: A systematic review of epidemiological data

International Journal of Clinical Practice

Volumn 67, Issue 1, 2013, Pages 32-45

  Seftel, A D ^a   De La Rosette, J ^b   Birt, J ^c   Porter, V ^d   Zarotsky, V ^d   Viktrup, L ^c  

^a Department of Anesthesiology   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c ELI LILLY AND COMPANY   (United States)

^d OPTUM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ATTITUDE TO ILLNESS; COMORBIDITY; DISEASE REGISTRY; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; ERECTILE DYSFUNCTION; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MASS SCREENING; PEER REVIEW; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SYSTEMATIC REVIEW;

AGE DISTRIBUTION; AGED; CONTROLLED CLINICAL TRIALS AS TOPIC; EPIDEMIOLOGIC METHODS; ERECTILE DYSFUNCTION; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; MOTIVATION; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITY OF LIFE;

EID: 84871405242     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12044     Document Type: Review

References (47)

1. Rosen R, Altwein J, Boyle P, et al., Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male. Eur Urol 2003; 44: 637-49.
2. Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH,. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical "Aging Male" symptoms? Results of the "Cologne Male Survey". Eur Urol 2003; 44: 588-94.
3. Andersson KE, de Groat WC, McVary KT, et al., Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn 2011; 30: 292-301.
4. Abrams P, Cardozo L, Fall M, et al., The standardization of terminology in lower urinary tract function: report from the standardization sub-committee of the International Continence Society. Urology 2003; 61: 37-49.
5. Irwin DE, Milsom I, Hunskaar S, et al., Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006; 50: 1306-14.
6. Barry MJ, Fowler FJ Jr, O'Leary MP, et al., The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-57.
7. Rosen RC, Riley A, Wagner G, et al., The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30.
8. Tikkinen KA, Auvinen A,. Does the imprecise definition of overactive bladder serve commercial rather than patient interests? Eur Urol 2012; 61: 746-8.
9. Link CLL, McKinlay JB,. Progression and remission of urologic symptoms: longitudinal results from the Boston Area Community Health (BACH) Survey. J Urol 2011; 185 (Suppl.): e1-938, American Urological Association abstract 58.
10. Schnetzler G, Banks I, Kirby M, et al., Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors. J Sex Med 2010; 7: 1237-46.
11. Baldwin K, Ginsberg P, Harkaway RC,. Under-reporting of erectile dysfunction among men with unrelated urologic conditions. Int J Impot Res 2003; 15: 87-9.
12. Shabsigh R, Kaufman J, Magee M, et al., Lack of awareness of erectile dysfunction in many men with risk factors for erectile dysfunction. BMC Urol 2010; 10: 18.
13. Conaglen HM, Conaglen JV,. Couples' reasons for adherence to, or discontinuation of, PDE type 5 inhibitors for men with erectile dysfunction at 12 to 24-month follow-up after a 6-month free trial. J Sex Med 2012; 9: 857-65.
14. Khoo EM, Tan HM, Low WY,. Erectile dysfunction and comorbidities in aging men: an urban cross-sectional study in Malaysia. J Sex Med 2008; 5: 2925-34.
15. Liu C-C, Huang S-P, Li W-M, et al., Are lower urinary tract symptoms associated with erectile dysfunction in aging males of Taiwan? Urol Int 2006; 77: 251-4.
16. Terai A, Ichioka K, Matsui Y, Yoshimura K,. Association of lower urinary tract symptoms with erectile dysfunction in Japanese men. Urology 2004; 64: 132-6.
17. Reggio E, de Bessa J Jr, Junqueira RG, et al., Correlation between lower urinary tract symptoms and erectile dysfunction in men presenting for prostate cancer screening. Int J Impot Res 2007; 19: 492-5.
18. Rhoden EL, Riedner CE, Fornari A, Costa Fuchs S, Porto Ribeiro E,. Evaluation of the association between lower urinary tract symptoms and erectile dysfunction, considering its multiple risk factors. J Sex Med 2008; 5: 2662-8.
19. El-Sakka Al,. Lower urinary tract symptoms in patients with erectile dysfunction: analysis of risk factors. J Sex Med 2006; 3: 144-9.
20. Demir O, Akgul K, Akar Z, et al., Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome. Aging Male 2009; 12: 29-34.
21. Ikuerowo SO, Akindiji YO, Akinoso OA, Akinlusi FM,. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men. Urol Int 2008; 80: 296-9.
22. Mehraban D, Naderi GH, Yahyazadeh SR, Amirchaghmaghi M,. Sexual dysfunction in aging men with lower urinary tract symptoms. J Urol 2008; 5: 260-4.
23. Ozayar A, Zumrutbas AE, Yaman O,. The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH. Int Urol Nephrol 2008; 40: 933-9.
24. Li MK, Garcia L, Patron N, et al., An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function. BJU Int 2008; 101: 197-202.
25. Braun M, Wassmer G, Klotz T, et al., Epidemiology of erectile dysfunction: results of the Cologne Male Survey. Int J Impot Res 2000; 12: 305-11.
26. Li M-K, Garcia LA, Rosen R,. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries. BJU Int 2005; 96: 1339-54.
27. Morant S, Bloomfield G, Vats V, Chapple C,. Increased sexual dysfunction in men with storage and voiding lower urinary tract symptoms. J Sex Med 2009; 6: 1103-10.
28. Bayraktar Z, Atun I,. Prevalence of self-reported erectile dysfunction among urological cases in Turkish men. Urol J 2011; 8: 214-21.
29. McVary K, Foley KA, Long SR, Sander S, Curtice TG, Shah H,. Identifying patients with benign prostatic hyperplasia through a diagnosis of, or treatment for, erectile dysfunction. Curr Med Res Opin 2008; 24: 775-84.
30. Hoesl CE, Woll EM, Burkart M, et al., Erectile dysfunction is prevalent, bothersome and under diagnosed in patients consulting urologists for benign prostatic syndrome. Eur Urol 2005; 47: 511-7.
31. Frankel SJ, Donovan JL, Peters TI, et al., Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 1998; 51: 677-85.
32. Tubaro A, Polito M, Giambroni L, Famulari C, Gange E, Ostardo E,. Sexual function in patients with LUTS suggestive of BPH. Eur Urol 2001; 40 (Suppl. 1): 19-22.
33. Leliefeld HHJ, Stoevelaar JH, McDonnell J,. Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. BJU Int 2002; 89: 208-13.
34. Kunelius P, Häkkinen J, Lukkarinen O,. Sexual functions in patients with benign prostatic hyperplasia before and after transurethral resection of the prostate. Urol Res 1998; 26: 7-9.
35. Rosen RC, Wei JT, Althof SE, et al., Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry. Urology 2009; 73: 562-6.
36. Chitale S, Collins R, Hull S, Smith E, Irving S,. Is the current practice providing an integrated approach to the management of LUTS and ED in primary care? An audit and literature review. J Sex Med 2007; 4: 1713-25.
37. Bacon CG, Mittleman MA, Kawachi I, et al., Sexual function in men older than 50 years of age: results from the Health Professionals follow-up study. Ann Intern Med 2003; 139: 161-8.
38. Oesterling JE,. The origin and development of benign prostatic hypertrophy. An age dependent process. J Andrology 1991; 12: 348-55.
39. Tsukamoto T, Kumamoto Y, Masumori N, et al., Prevalence of prostatism in Japanese men in a community based study with comparison to a similar American study. J Urol 1995; 154: 391-5.
40. Lee E, Yoo KY, Kim Y, et al., Prevalence of lower urinary tract symptoms in Korean men in a community-based study. Eur Urol 1998; 33: 17-21.
41. Homma Y, Kawabe K, Tsukamoto T, et al., Estimate criteria for diagnosis and severity in benign prostatic hyperplasia. Int J Urol 1996; 3: 261-266.
42. Bouwman II, van der Heide WK, van der Meer K, Nijman R,. Correlations between lower urinary tract symptoms, erectile dysfunction, and cardiovascular diseases. Are there differences between male populations from primary healthcare and urology clinics? A review of the current knowledge. Eur J Gen Pract 2009; 15: 128-35.
43. Hall SA, Link CL, Hu JC, Eggers PW, McKinlay JB,. Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample. BJU Int 2009; 104: 1680-8.
44. Jacobsen SJ, Jacobson DJ, Girman CJ, et al., Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted county study of urinary symptoms and health status. J Urol 1999; 162: 1301-6.
45. De Boer BJ, Bots ML, Nijeholt AA, Moors JP, Verheij TJ,. The prevalence of bother, acceptance, and need for help in men with erectile dysfunction. J Sex Med 2005; 2: 445-50.
46. Gacci M, Eardley I, Giuliano F, et al., Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2011; 60: 809-825.
47. Rosen R, Giuliano F, Carson CC,. Sexual dysfunction and lower urinary tract symptoms associated with BPH. Eur Urol 2005; 47: 824-837.